Intrexon and AquaBounty to Collaborate on Leveraging Synthetic Biology to Increase Productivity Across the Aquaculture Arena Exclusive Channel Collaboration Driven by Need to Meet Growing World Food Demand Intrexon Proposes to Invest Up to $6.0 Million in AquaBounty GERMANTOWN, Md. and MAYNARD, Mass., Feb. 15, 2013...

Intrexon Completes Mandatory Tender Offer for AquaBounty Technologies Shares BLACKSBURG, Va., Jan. 7, 2013 (GLOBE NEWSWIRE) -- Intrexon Corporation, a synthetic biology company that utilizes its proprietary technologies to provide control over cellular function, today...

Intrexon to Acquire 48% Stake in AquaBounty Technologies BLACKSBURG, Va., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Intrexon Corporation, a synthetic biology company that utilizes its proprietary technologies to provide control over cellular function, today...

BioLife Cell Bank and Intrexon Establish Worldwide Exclusive Collaboration for Spinal Muscular Atrophy (SMA) DALLAS and GERMANTOWN, Md., Aug. 2, 2012 (GLOBE NEWSWIRE) -- BioLife Cell Bank, Inc., the leader in cryogenic storage of adipose (fat) tissue and adult mesenchymal stem and regenerative cells, and...